Harvard Bioscience, Inc.
HBIOHarvard Bioscience, Inc.
NASDAQ
Healthcare
Medical - Instruments & Supplies
$5.16
+0.07(1.4%)
52W $2.84 – $7.87
AI-generated
Harvard Bioscience, Inc.
Revenue breakdown: Instruments Equipment Software And Accessories (91.4%), Service Maintenance And Warranty Contracts (8.6%).
$23MMkt Cap
$87MRev TTM
-$57MNI TTM
-0.4xP/E TTM
Latest Earnings
10-K
FY FY2025Mar 12, 2026Harvard Bioscience, Inc. reported a challenging fiscal year 2025 with revenues of $86.5 million, representing an 8.1% decrease from $94.1 million in 2024. The company recorded a significant net loss of $56.7 million, primarily driven by a $48.0 million goodwill impairment charge. Despite the loss, the company generated positive operating cash flow of $6.7 million and maintained a cash balance...
What Changed Recently
Fundamentals
How The Business Makes Money
Revenue by Segment
Instruments Equipment Software And Accessories91.4%($165M)
Service Maintenance And Warranty Contracts8.6%($15M)
Revenue by Geography
US44.7%($81M)
EMEA30.5%($55M)
CN13.4%($24M)
Asia Other7.6%($14M)
Americas Other3.8%($7M)
Analyst View
Company Profile
CIK0001123494
ISINUS4169061052
CUSIP416906105
Phone508 893 8999
Address84 October Hill Road, Holliston, MA, 01746, US
SEC EDGAR